SCHEMBL29969255

SCHEMBL29969255

COc1cccc(S(=O)(=O)Cl)c1OC

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.49
HTR6 P50406 1/20 0.46
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA14 Q9ULX7 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
NFE2L2 Q16236 6/20 0.41
KCNH2 Q12809 1/20 0.40
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA4 P22748 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PRMT1 Q99873 1/20 0.39
ODC1 P11926 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1713241 1.00 TRPV4 (0.49) TRPV4HTR6CA12CA1CA2
SCHEMBL11138757 0.88 TRPV4 (0.46) TRPV4HTR6CA12CA1CA2
SCHEMBL7333547 0.84 HTR6 (0.44) TRPV4HTR6SMN1; SMN2NFE2L2KCNH2
SCHEMBL6912891 0.84 HTR6 (0.53) HTR6CA12CA1CA2CA14
SCHEMBL2494769 0.84 SMN1; SMN2 (0.48) HTR6CA12CA1CA2CA14
SCHEMBL668439 0.82 HTR6 (0.47) HTR6CA12CA1CA2CA14
SCHEMBL6968672 0.82 HTR6 (0.47) HTR6CA12CA1CA2CA14
SCHEMBL9252637 0.82 SMN1; SMN2 (0.47) HTR6CA12CA1CA2CA14
SCHEMBL29785793 0.82 TRPV4 (0.55) TRPV4SMN1; SMN2LMNANPSR1NPC1
SCHEMBL2494766 0.82 TRPV4 (0.55) TRPV4SMN1; SMN2LMNANPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492346-B2 Benzisoxazole sulfonamide derivatives PFIZER INC. (US) 2022-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492346-B2 Benzisoxazole sulfonamide derivatives BRIX1, RB1, BCR TRPV4 2910/4885HTR6 4252/4885CA12 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.